Charles River acquires microbe testing lab

Contract Research |  News | By BioSpectrum Bureau  | 0 Comment | 06 Nov, 2013

Singapore: Charles River has acquired Brass, a Singapore-based microbiology subcontract test laboratory specializing in endotoxin testing, bacterial and fungal identification. The objectiv...Read more

Australia to boost clinical trial landscape

Contract Research |  News | By BioSpectrum Bureau  | 0 Comment | 22 Aug, 2014

Singapore: Australia's National Health and Medical Research Council (NHMRC) has taken up the task of implementing initiatives to make the process of starting and conducting clinical trials ...Read more

WuXi PharmaTech appoints William Keller to Board

Contract Research |  Influencers | By BioSpectrum Bureau  | 0 Comment | 01 Oct, 2014

Singapore: China bioscience service provider, WuXi PharmaTech, has appointed Mr William Robert Keller as an independent director on the Board of Directors to serve on strategy committee. M...Read more

Evolving trends in clinical trial designs

Contract Research |  Opinion | By BioSpectrum Bureau  | 0 Comment | 09 Oct, 2014

In the current competitive era of drug development, establishing the superiority of a new medical intervention compared to a relevant standard with a big effect size is difficult. If a mode...Read more

Strategic site selection could help reduce study delays

Contract Research |  Opinion | By BioSpectrum Bureau  | 0 Comment | 09 Oct, 2014

With surveys indicating that 70 percent of clinical trials across Asia, Europe, Canada and Latin America experience delays and only 15 percent of Asian trials are completed on time1,2 â”...Read more

Australian CRO Novotech opens new office in India

Contract Research |  News | By BioSpectrum Bureau  | 0 Comment | 29 Jun, 2015

Singapore: Further expanding its presence in Asia, Australia's leading Contract Research Organization Novotech recently inaugurated its its new office in Bangalore, India. The inauguration ...Read more

WuXi Pharma ventures into Israel

Contract Research |  News | By BioSpectrum Bureau  | 0 Comment | 04 Nov, 2014

Singapore: China headquarterd WuXi PharmaTech has expanded its presence in Israel to provide integrated R&D services to local customers. The R&D service provider has collaborated w...Read more

Dishman might sell China plant to clear debts

Contract Research |  News | By BioSpectrum Bureau  | 0 Comment | 13 Jan, 2014

Singapore: India's Ahmedabad based contract research and manufacturing services (CRAMS) company Dishman Pharmaceuticals and Chemicals is said to be looking at selling its China based plant ...Read more

Clinical Outsourcing Models: "Drive a Hybrid"

Contract Research |  Opinion | By BioSpectrum Bureau  | 0 Comment | 02 Jun, 2015

Singapore: When we think "hybrid" we think of taking the best components from often opposing approaches and forming a new optimised solution. We think hybrid car; the hybrid cloud; maybe ev...Read more

Parexel acquires Turkish firm

Contract Research |  News | By BioSpectrum Bureau  | 0 Comment | 02 Jul, 2014

Singapore: Parexel, a global clinical research organization with strong base in Asia, has acquired all outstanding equity securities of Atlas Medical Services, a provider of clinical resear...Read more

GVK announces successful completion of project

Contract Research |  News | By BioSpectrum Bureau  | 0 Comment | 22 Oct, 2014

Singapore: GVK biosciences has announced the successful completion of in-silico based alternative indications of shelved compounds using GVK BIO's proprietary Drug Re-purposing platform for...Read more

USFDA issues haunts Jubilants's Q1 growth

Contract Research |  Company results | By BioSpectrum Bureau  | 0 Comment | 07 Aug, 2014

India: The board of Jubilant Life Sciences, an integrated pharmaceutical and lifesciences company met on August 06, 2014 to approve financial results for the quarter ended June 30, 2014. C...Read more

WuXi to establish presence in Boston, SF by 2015

Contract Research |  News | By BioSpectrum Bureau  | 0 Comment | 16 Dec, 2014

Singapore: China-based research and development service provider, WuXi PharmaTech, plans to expand its operations in US by opening offices in Boston and San Francisco by early 2015. The co...Read more

PPD forms JV to tap Japan clinical trial market

Contract Research |  News | By BioSpectrum Bureau  | 0 Comment | 09 Apr, 2015

Singapore: Pharmaceutical Product Development (PPD) and Japan based Shin Nippon Biomedical Laboratories (SNBL) have formed a joint venture to provide clinical development services in Japan....Read more

PAREXEL launches clinical trial data monitor solution

Contract Research |  News | By BioSpectrum Bureau  | 0 Comment | 21 May, 2014

Singapore: PAREXEL International has launched an integrated suite of applications for managing clinical trials called Perceptive MyTrials Data-Driven Monitoring solution. On-site monitorin...Read more

PPD appoints Mr Robert Hureau as CFO

Contract Research |  Influencers | By BioSpectrum Bureau  | 0 Comment | 26 Aug, 2014

Singapore: Pharmaceutical Product Development, (PPD) has appointed Mr Robert Hureau as executive vice president and chief financial officer. "Bob is an accomplished chief financial officer ...Read more

WuXi Pharma launches mobile app for research services

Contract Research |  News | By BioSpectrum Bureau  | 0 Comment | 06 Jan, 2015

Singapore: China's research contract service provider, WuXi PharmaTech, has launched WuXi V-Lab, a mobile app available to the global research community in need of small-molecule compound s...Read more

Response Genetics renews deal with Taiho Pharma

Contract Research |  News | By BioSpectrum Bureau  | 0 Comment | 23 Jul, 2013

Singapore: US-based Response Genetics, a company focused on the development and sale of molecular diagnostic tests that help determine a patient's response to cancer therapy, announced exte...Read more